Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
the ceo of this company probably doesnt know one individual in the fda. his power is O
gilead up 13 dollars in after hours. the ceo od gilead has pull with the fda. wish i could say the same with the ceo of cydy
you call that a answer, my grandchild could have answered that better than he did
hey TMACK nobody gives a fooook what you did today. keep your trading to yourself
after seeing this video with ryan lange today. i just dont understand how the stock price is this low. he stated WE ARE SHIPPING EVERYDAY.
why is the fda ignoring this drug that is saving lives. all attention is on gileads drug
you people are talking about non issues. the big issue is the 5 patients results today in trial.
yeah that was a great video
i think the shorts are in big trouble betting against LERONLIMAB
i just had to buy more, i just couldnt help it
there going to try to get approval with the fda. ceo just said on proactive investor video
3 more patients taken off ventilators with leronlimab in california
great find, the news is finally spreading
you get this stock on the nasdaq and boom its at 5 dollars
denis just did a interview with proactive investors. hes speaking with the nasdaq about uplisting to the nasdaq
I THINK NEXT GREEN WAVE IS KILLING 2 BIRDS WITH 1 STONE. AT THE END OF APRIL THEY WILL BE DOING THE 2019 4TH QUARTER FINANCIALS AND THEY WILL ALSO BE DOING THE 2020 FIRST QUARTER RESULTS
the market cap on this stock is not going higher as long as its on the OTC
no penny stock has a market cap of 1.4 billion dollars
cytodyn just partnered with novant health corp. just announced
its because the OTC is a penny traders heaven. if this was on the nasdaq the market cap would be 2 billion by now
the ceo on proactive investor said big news coming at 11:45am on charles payne. i didnt hear any new news at all
the ceo didnt give any new info on patients
the OTC is a joke. finally the ceo realizes that
looks like denis is meeting requirements to get to the NASDAQ in the filing report today. finally some good news
looks like denis is meeting requirements to get to the NASDAQ in the filing report today. finally some good news
i ask ryan lange to speak at next quartely and to give us some guidance going forward but he hasnt got back to me since
proactive investor video strikes again today
yeah and i wont stop posting it till they get off this penny trader platform
yes the proactive video is on twitter on cytodyn twitter page. the ceo more info coming out tommorrow on rest of the patients
ok i will ask him
ryan lange just started answering my personal messages that i send him on instagram. i think hes becoming more transparent
ryan lange on twitter just posted that they are selling slurricane faster than they can make it. he says its selling out everywhere
proactive inestors just out with new video with ceo and dr. patterson
here we go again, not one word on leronlimab in virus briefing again today
gilead stock futures are exploding im hearing. you see they have a legit ceo. cytodyn ceo has no pull with the fda. this is going to hurt investors
LERONLIMAB will be used for pneumonia and bronchitis down the road. pneumonia is the number one killer in the world
good job finding this
as a shareholder myself well must all as shareholders spread the news about LERONLIMAB on twitter, facebook, instagram and stocktwits. we cannot rely on our ceo to get the word out. sorry to say he doesnt have that much pull with the fda. so pleazse everybody spread the news whereever you can
ryan lange put out a video on twitter with tons of barrells of wedding cake
everybody here on this site should start promoting LERONLIMAB on twitter, facebook, instagram and stocktwits. we cannot rely on this ceo to step up so we must step up as investors. dont count on the ceo